Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 10Pain, Postoperative 9Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Lung Neoplasms 8Stomach Neoplasms 6Colonic Neoplasms 6Brain Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Colorectal Neoplasms 5Agnosia 4Thromboembolism 3Pain 3Ovarian Neoplasms 3Myofibroma 3Head and Neck Neoplasms 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Neoplasm Metastasis 2Leiomyoma 2Hemangioma 2Arthritis, Rheumatoid 2Vomiting 1Visceral Pain 1Uterine Cervical Neoplasms 1

Interventions

Cisplatin 72Brachytherapy 31Radiotherapy 26Paclitaxel 23Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21human papillomavirus vaccine, L1 type 16, 18 20Topotecan 18Papillomavirus Vaccines 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 16pembrolizumab 14Radiation 12Gemcitabine 12Early Intervention, Educational 12Colposcopy 12Methods 11Magnetic Resonance Spectroscopy 11atezolizumab 10Radiotherapy, Intensity-Modulated 10Blood Specimen Collection 10Papanicolaou Test 9Docetaxel 9Vaccines, Synthetic 8Platinum 8Nivolumab 8Ipilimumab 8Counseling 81,2-diaminocyclohexaneplatinum II citrate 8Vaccines 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Neoplasms × Saline Solution × Clear all
NCT03635567 2026-02-04

KEYNOTE-826

Merck Sharp & Dohme LLC

Phase 3 Completed
617 enrolled 29 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡